UCSF

Phillips discusses insurance coverage for genomic testing

Kathryn Phillips, PhD, discusses insurance coverage for genomic testing in her recent articles published in JAMA and Science.

In a JAMA Viewpoint, April 16, Phillips examines the new CMS coverage policy for genomic tests in cancer patients: “Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?

In a letter in Science, April 20, she considers: “Insurance coverage for genomic tests.”

Phillips is a faculty member in the Department of Clinical Pharmacy. She is a health services and policy researcher and health economist, and the founding director of the TRANSPERS Center (Center for Translational and Policy Research on Personalized Medicine).


About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.